SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (2536)10/28/1997 1:52:00 PM
From: Randy Schmid  Read Replies (2) of 6136
 
Waterhouse is all gummed up too - plus my corp server was jammed - I think everybody was glued to the market today. Phones were busy at the branch office too. May 45s and 50s sitting out there, just can't get your hand through the fence to pluck the low hanging fruit!

Congrats on getting in at 42 1/8 Tom! I still don't know if I sold out of the AGPH Nov 47.5s - probably did - at about break even.

Looked at another way, if the price moves up as the market stabilizes, then the previous investments will be in better shape. If it drops more, then there's more buying opportunities there, and if it remains the same, at least you'll be able to buy!

Hear comments about downgrade of Merck having to do with poorer performance of several drugs, including Crixivan (I think it was CNBC that mentioned this), but don't know if AGPH or Vira got a mention. It doesn't seem fair that MRK would get downgraded but no one wanted to buy AGPH as the beneficiary...

Feeling better,

Randy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext